Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) will hold a conference call on April 29, 2021, at 5:00 PM ET to discuss its Q1 2021 financial results and revenue guidance for Q2 and the full year 2021. The call will cover recent business developments and provide insights into the company's financial outlook. Investors can join via telephone or webcast. For more details and to access the replay, visit the Emergent website.

GAITHERSBURG, Md., April 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 29, 2021 at 5:00 pm eastern time to discuss the financial results for the first quarter of 2021, recent business developments, revenue guidance for the second quarter of 2021, and financial outlook for full year 2021.

This conference call can be accessed live by telephone or by webcast:

	Teleconference Information: Dial in number – toll-free: (855) 766-6521 Dial in number – toll: (262) 912-6157 Conference ID: 9153099
	Webcast Information:
	Visit https://edge.media-server.com/mmc/p/yvrb3cpe for the live webcast.

A replay of the call can be accessed from the Emergent website.

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
burrowsr@ebsi.com

Media Contact:
Matt Hartwig
Director, Media Relations
mediarelations@ebsi.com

FAQ

When is the Emergent BioSolutions Q1 2021 earnings call?

The conference call is scheduled for April 29, 2021, at 5:00 PM ET.

How can I join the Emergent BioSolutions earnings call?

You can join via telephone at (855) 766-6521 or through the webcast on the Emergent website.

What will be discussed during the Emergent BioSolutions earnings call?

The call will cover Q1 financial results, recent business developments, and revenue guidance for Q2 and the full year 2021.

Where can I find the Emergent BioSolutions earnings call replay?

The replay can be accessed from the Emergent BioSolutions website after the call.